The primary objective of this study is to determine the optimal dose of S-600918 in patients with refractory chronic cough by evaluating the change from baseline in 24-hour cough frequency (coughs per hour) with S-600918 compared with placebo.
|Treatment||S-600918, Placebo to S-600918|
|Clinical Study Identifier||NCT04110054|
|Last Modified on||18 November 2020|
Select a piece of text and start making personal notes.
Congrats! You have your own personal workspace now.